![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Ovarian Neoplasms |
|
Free Subscription
1 Am J Obstet Gynecol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Ovarian Neoplasms is free of charge.
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in
NBN: a systematic review and meta-analysis.
Am J Obstet Gynecol. 2026 Feb 16:S0002-9378(26)00084.
PubMed
Abstract available
A Deeper Dive into POLE-Mutated Endometrial Carcinomas: The Contributions and
Consequences of Tumor Mutational Burden.
Am J Surg Pathol. 2025 Dec 24. doi: 10.1097/PAS.0000000000002503.
PubMed
Abstract available
Tele-emotion regulation therapy versus tele-guided imagery therapy on sexual
performance anxiety in endometrial and ovarian cancer: a randomized clinical
trial.
BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-025-15180.
PubMed
Abstract available
Immunochemotherapy regimen demonstrates survival benefits for patients with
platinum-resistant ovarian cancer.
Cancer. 2026;132:e70251.
PubMed
Correction to "Association of alcohol intake over the lifetime with colorectal
adenoma and colorectal cancer risk in the Prostate, Lung, Colorectal, and Ovarian
Cancer Screening Trial".
Cancer. 2026;132:e70324.
PubMed
Pre-diagnosis thyroid dysfunction and ovarian cancer risk and survival: a
prospective cohort study.
J Natl Cancer Inst. 2026 Feb 18:djag055. doi: 10.1093.
PubMed
Abstract available
Adjuvant Chemotherapy in Stage I Ovarian Clear Cell Carcinoma: A Systematic
Review and Meta-analysis.
Obstet Gynecol. 2026;147:344-354.
PubMed
Abstract available
TFAP2C protects against ferroptosis in ovarian cancer through the KEAP1-NRF2 axis
by recruiting HDAC1/2.
Oncogene. 2026 Feb 17. doi: 10.1038/s41388-026-03692.
PubMed
Abstract available
Tumor cell-intrinsic PD-1 in malignant ascites drives ovarian cancer progression
via MAPK/ERK signaling.
Oncogene. 2026 Feb 17. doi: 10.1038/s41388-026-03693.
PubMed
Abstract available
Thank you for your interest in scientific medicine.